The only natural host of the hepatitis C virus (HCV) is humans. Model organisms for laboratory studies, especially mice, cannot be infected which makes the search for a vaccine against HCV extremely difficult because...
The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to antiviral therapies and diagnostics. However, to safely harness their powers, scientists are searching...
Strengthening our microbiome with a pill so that it can effectively fight diseases? HZI researchers are striving to make this vision of the future a reality.
A conversation with Prof. Andreas Keller from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Prof. Yang Li from the Centre for Individualised Infection Medicine (CiiM) about artificial...
Infectious keratitis blinds 1.5 million people worldwide every year. This severe eye disease is often caused by the hospital germ Pseudomonas aeruginosa, which the World Health Organization considers one of the most...
A hospital is a place where you generally don't like to go, but are glad that it's there when you need it. It's called ‘clinically clean’. But it is precisely here that we also encounter the term “hospital germ” – an...
Dr Natalia Torow researches the immune system of newborns, seeking to understand how it responds to pathogens and vaccinations to better prevent early-life infections. Since 2024, she has led the junior research group...
The European Research Council (ERC) has announced the results of the latest round of its “Proof of Concept Grant” 2024 competition. Among the researchers selected for funding is Prof. Yang Li, co-director of the Centre...
Construction of a modern new building for the Helmholtz Institute for One Health (HIOH) will begin this year on the University of Greifswald's Berthold-Beitz-Platz campus. Founded in 2021 as a site of the Helmholtz...